Published in BMC Res Notes on November 23, 2010
Metabolic Characterization of Advanced Liver Fibrosis in HCV Patients as Studied by Serum 1H-NMR Spectroscopy. PLoS One (2016) 0.79
Comparative salivary proteome of hepatitis B- and C-infected patients. PLoS One (2014) 0.75
Up-Regulation of Antioxidant Proteins in the Plasma Proteome during Saturation Diving: Unique Coincidence under Hypobaric Hypoxia. PLoS One (2016) 0.75
A Systematic Review of Des-γ-Carboxy Prothrombin for the Diagnosis of Primary Hepatocellular Carcinoma. Medicine (Baltimore) (2016) 0.75
Reverse lectin ELISA for detecting fucosylated forms of α1-acid glycoprotein associated with hepatocellular carcinoma. PLoS One (2017) 0.75
Primary liver cancer: worldwide incidence and trends. Gastroenterology (2004) 11.21
Des-gamma-carboxy prothrombin and alpha-fetoprotein as biomarkers for the early detection of hepatocellular carcinoma. Gastroenterology (2009) 4.90
Alpha-fetoprotein, des-gamma carboxyprothrombin, and lectin-bound alpha-fetoprotein in early hepatocellular carcinoma. Gastroenterology (2009) 4.50
Alpha-1-acid glycoprotein. Biochim Biophys Acta (2000) 3.00
Serum alpha-fetoprotein levels in patients with advanced hepatitis C: results from the HALT-C Trial. J Hepatol (2005) 2.63
Des-gamma carboxyprothrombin can differentiate hepatocellular carcinoma from nonmalignant chronic liver disease in american patients. Hepatology (2003) 2.05
Alpha-fetoprotein: reevaluation in hepatology. Hepatology (1990) 1.83
AFP-L3: a new generation of tumor marker for hepatocellular carcinoma. Clin Chim Acta (2001) 1.51
Multicenter prospective analysis of newly diagnosed hepatocellular carcinoma with respect to the percentage of Lens culinaris agglutinin-reactive alpha-fetoprotein. J Gastroenterol Hepatol (2001) 1.33
Production of abnormal prothrombin (des-gamma-carboxy prothrombin) by hepatocellular carcinoma. A clinical and experimental study. J Hepatol (1987) 1.32
Sensitivity and specificity of des-gamma-carboxy prothrombin for diagnosis of patients with hepatocellular carcinomas varies according to tumor size. Am J Gastroenterol (2006) 1.29
Utility of Lens culinaris agglutinin-reactive fraction of alpha-fetoprotein and des-gamma-carboxy prothrombin, alone or in combination, as biomarkers for hepatocellular carcinoma. Clin Gastroenterol Hepatol (2008) 1.26
Unique clinical characteristics of patients with hepatocellular carcinoma who present with high plasma des-gamma-carboxy prothrombin and low serum alpha-fetoprotein. Cancer (2000) 1.13
Plasma des-gamma-carboxyprothrombin in the early stage of hepatocellular carcinoma. Hepatology (1990) 1.04
Clinical evaluation of plasma des-gamma-carboxy prothrombin as a marker protein of hepatocellular carcinoma in patients with tumors of various sizes. Dig Dis Sci (1993) 0.99
Relationship between serum alpha-foetoprotein, cirrhosis and survival in hepatocellular carcinoma. Br J Cancer (1981) 0.95
Significance of alpha-fetoprotein levels for detection of early recurrence of hepatocellular carcinoma after hepatic resection. J Surg Oncol (1997) 0.89
Combination of alpha-1-acid glycoprotein and alpha-fetoprotein as an improved diagnostic tool for hepatocellular carcinoma. Clin Chim Acta (2008) 0.87
Serum protein biomarkers screening in HCC patients with liver cirrhosis by ICAT-LC-MS/MS. J Cancer Res Clin Oncol (2010) 0.86
The des-gamma-carboxyprothrombin for the diagnosis of hepatocellular carcinoma. Ital J Gastroenterol (1993) 0.80
The putative use of alpha-1-acid glycoprotein as a non-invasive marker of fibrosis. Biomed Chromatogr (2006) 0.78
Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma. Hepatol Int (2010) 5.02
How common is non-alcoholic fatty liver disease in the Asia-Pacific region and are there local differences? J Gastroenterol Hepatol (2007) 2.48
Consensus on extra-hepatic portal vein obstruction. Liver Int (2006) 1.47
Noncirrhotic portal fibrosis/idiopathic portal hypertension: APASL recommendations for diagnosis and treatment. Hepatol Int (2007) 1.24
Liver fibrosis: consensus recommendations of the Asian Pacific Association for the Study of the Liver (APASL). Hepatol Int (2008) 1.04
Genetic factors contribute to patient-specific warfarin dose for Han Chinese. Clin Chim Acta (2008) 1.04
Re-evaluating transarterial chemoembolization for the treatment of hepatocellular carcinoma: Consensus recommendations and review by an International Expert Panel. Liver Int (2013) 1.04
Hepatocarcinogenesis in viral Hepatitis B infection: the role of HBx and p53. Acta Med Indones (2006) 1.03
Consensus recommendations and review by an International Expert Panel on Interventions in Hepatocellular Carcinoma (EPOIHCC). Liver Int (2013) 1.00
Hepatitis B virus subgenotypes and basal core promoter mutations in Indonesia. World J Gastroenterol (2009) 0.97
Diagnostic value of a group of biochemical markers of liver fibrosis in patients with non-alcoholic steatohepatitis. J Dig Dis (2009) 0.96
Primary prophylaxis of gastroesophageal variceal bleeding: consensus recommendations of the Asian Pacific Association for the Study of the Liver. Hepatol Int (2008) 0.96
Deep vein thrombosis in patients with advanced liver cirrhosis: a rare condition? Hepatol Int (2010) 0.89
Hepatitis B virus genotypes/subgenotypes in voluntary blood donors in Makassar, South Sulawesi, Indonesia. Virol J (2009) 0.88
Combination of alpha-1-acid glycoprotein and alpha-fetoprotein as an improved diagnostic tool for hepatocellular carcinoma. Clin Chim Acta (2008) 0.87
Genotype diversity of hepatitis C virus (HCV) in HCV-associated liver disease patients in Indonesia. Liver Int (2010) 0.87
Diagnostic accuracy of transient elastography (FibroScan) versus the aspartate transaminase to platelet ratio index in assessing liver fibrosis in chronic hepatitis B: the role in primary care setting. J Clin Pathol (2011) 0.86
Hepatitis C virus genotype in blood donors and associated liver disease in Indonesia. Intervirology (2009) 0.85
Microorganisms and parasites in chronic infective diarrhea. Acta Med Indones (2005) 0.84
Low prevalence of hepatitis B virus pre-S deletion mutation in Indonesia. J Med Virol (2011) 0.84
Demographic, clinical, and virological characteristics of hepatocellular carcinoma in Asia: survey of 414 patients from four countries. J Med Virol (2002) 0.83
Association of core promoter mutations of hepatitis B virus and viral load is different in HBeAg(+) and HBeAg(-) patients. World J Gastroenterol (2011) 0.82
Hepatitis B virus pre-S2 start codon mutations in Indonesian liver disease patients. World J Gastroenterol (2012) 0.82
Reactivation of hepatitis B virus associated with chemotherapy and immunosuppressive agent. Acta Med Indones (2013) 0.81
Immunoregulatory effects of AFP domains on monocyte-derived dendritic cell function. BMC Immunol (2011) 0.81
The effect of L-ornithine L-aspartate and branch chain amino acids on encephalopathy and nutritional status in liver cirrhosis with malnutrition. Acta Med Indones (2011) 0.80
Detection of esophageal varices in liver cirrhosis using non-invasive parameters. Acta Med Indones (2005) 0.80
Significant hepatic histopathology in chronic hepatitis B patients with serum ALT less than twice ULN and high HBV-DNA levels in Indonesia. J Dig Dis (2011) 0.79
Alpha-fetoprotein gene polymorphisms and risk of HCC and cirrhosis. Clin Chim Acta (2009) 0.78
Reimbursement policies in the Asia-Pacific for chronic hepatitis B. Hepatol Int (2014) 0.78
Grade 3-4 liver enzyme elevation during HAART in HIV and hepatitis C co-infected adults. Acta Med Indones (2009) 0.77
Antibody and markers of T-cell activation illuminate the pathogenesis of HCV immune restoration disease in HIV/HCV co-infected patients commencing ART. Clin Immunol (2011) 0.77
Examination of small bowel enzymes in chronic diarrhea. J Gastroenterol Hepatol (2003) 0.76
An observational study to evaluate the safety and efficacy of telbivudine in adults with chronic hepatitis B. Acta Med Indones (2014) 0.76
Acute liver failure related to chemotherapy. Acta Med Indones (2012) 0.75
Association between Serum Uric Acid and Non-Alcoholic Fatty Liver Disease: A Meta-Analysis. Acta Med Indones (2017) 0.75
Treatment Response Monitoring of Chronic Hepatitis B Patients using Transient Elastography and Aspartate Aminotransferase-to-Platelet Ratio Index (APRI). Acta Med Indones (2017) 0.75
Mortality-related Factors in Patients with Malignant Obstructive Jaundice. Acta Med Indones (2016) 0.75
Prognostic in sarcoma Ewing. Acta Med Indones (2006) 0.75
Two new standard reference materials for the determination of drugs of abuse in human hair. Anal Bioanal Chem (2003) 0.75
Metrologic traceability of total thyroxine measurements in human serum: efforts to establish a network of reference measurement laboratories. Clin Chem (2004) 0.75
Hepatocellular Carcinoma in a Tertiary Referral Hospital in Indonesia: Lack of Improvement of One-Year Survival Rates between 1998-1999 and 2013-2014. Asian Pac J Cancer Prev (2016) 0.75
Prevalence and Profile of Fibrosis in Diabetic Patients with Non-alcoholic Fatty Liver Disease and the Associated Factors. Acta Med Indones (2017) 0.75
Clinical picture, insulin resistance, and adipocytokines profiles of nonalcoholic steatohepatitis (NASH) patients in Indonesia. Acta Med Indones (2009) 0.75
Evaluation of Acoustic Radiation Force Impulse (ARFI) for Fibrosis Staging in Chronic Liver Diseases. Acta Med Indones (2017) 0.75
Detection rate of colorectal adenoma or cancer in unselected colonoscopy patients: Indonesian experience in a private hospital. Asian Pac J Cancer Prev (2014) 0.75
Colloids Versus Albumin in Large Volume Paracentesis to Prevent Circulatory Dysfunction: Evidence-based Case Report. Acta Med Indones (2016) 0.75
Influence of the sorafenib patients assistance program on treatment compliance and overall survival of unresectable hepatocellular carcinoma patients. Acta Med Indones (2012) 0.75
Hepatic cirrhosis caused by Caroli disease. Acta Med Indones (2005) 0.75
Performance of Alpha Fetoprotein in Combination with Alpha-1-acid Glycoprotein for Diagnosis of Hepatocellular Carcinoma Among Liver Cirrhosis Patients. Acta Med Indones (2015) 0.75